{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:26:39Z","timestamp":1794212799291,"version":"4.8.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.psychres.2026.117024","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:50:49Z","timestamp":1771433449000},"page":"117024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sigma-1 receptor antagonism as a potential mechanism of sertraline-associated Alice in Wonderland syndrome"],"prefix":"10.1016","volume":"359","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.psychres.2026.117024_bib0001","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209957","article-title":"Teaching neuroimage: alice in wonderland syndrome: anatomic correlation","volume":"103","author":"Allen","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2026.117024_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.668633","article-title":"Time distortions: a systematic review of cases characteristic of Alice in Wonderland syndrome","volume":"12","author":"Blom","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117024_bib0003","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.27015","article-title":"Lesions causing Alice in Wonderland syndrome map to a common brain network linking body and size perception","volume":"96","author":"Friedrich","year":"2024","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.psychres.2026.117024_bib0004","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00406-020-01231-x","article-title":"Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor","volume":"271","author":"Hashimoto","year":"2021","journal-title":"Eur. Arch. Psychiatry. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.psychres.2026.117024_bib0005","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41380-021-01432-3","article-title":"Mechanisms of action of fluvoxamine for COVID-19: a historical review","volume":"27","author":"Hashimoto","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117024_bib0006","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.psychres.2026.117024_bib0007","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/14728222.2011.560837","article-title":"Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders","volume":"15","author":"Hayashi","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.psychres.2026.117024_bib0008","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2014.01.064","article-title":"Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells","volume":"727","author":"Ishima","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2026.117024_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8243145","article-title":"Alice in Wonderland Syndrome: a clinical and pathophysiological review","volume":"2016","author":"Mastria","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.psychres.2026.117024_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116920","article-title":"Alice in wonderland syndrome: down the rabbit hole of VigiBase\u00ae","volume":"356","author":"Merino","year":"2026","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.psychres.2026.117024_bib0011","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/HRP.0000000000000439","article-title":"Pharmacological treatment of hallucinogen persisting perception disorder (HPPD): a systematic review","volume":"33","author":"Neven","year":"2025","journal-title":"Harv. Rev. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2026.117024_bib0012","doi-asserted-by":"crossref","first-page":"e2558","DOI":"10.1371\/journal.pone.0002558","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways","volume":"3","author":"Nishimura","year":"2008","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.psychres.2026.117024_bib0013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2026.117024_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13854046.2025.2577141","article-title":"Alice in Wonderland Syndrome: a review & cognitive case report","volume":"22","author":"Towns","year":"2025","journal-title":"Clin. Neuropsychol."},{"issue":"8","key":"10.1016\/j.psychres.2026.117024_bib0015","article-title":"When Alice took sertraline: a case of sertraline-induced Alice in Wonderland syndrome","volume":"12","author":"Vilela","year":"2020","journal-title":"Cureus"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:13:36Z","timestamp":1794212016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":15,"alternative-id":["S0165178126000855"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117024","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sigma-1 receptor antagonism as a potential mechanism of sertraline-associated Alice in Wonderland syndrome","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117024"}}